Miguel Viveiros
Miguel Viveiros publishes mostly in Infectious Diseases, Epidemiology and Molecular Biology, on topics such as Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and Antibiotic Resistance in Bacteria.
- World rank
- #442,219 of 7,710,434 ranked researchers
- Rank in Portugal
- #1,387 of 41,760
- Works
- 329
- Citations
- 13k
- Citations per work
- 41.0
What does Miguel Viveiros research?
Miguel Viveiros's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (23%), Chemistry (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13541.0%
- Medicine13541.0%
- Everything else9829.8%
- Life Sciences7422.5%
- Physical Sciences226.7%
- Chemistry226.7%
- 1Infectious Diseases22% of their works
- 2Epidemiology15% of their works
- 3Molecular Biology14% of their works
- 4Molecular Medicine8% of their works
- 5Organic Chemistry7% of their works
- 6Surgery4% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Antibiotic Resistance in Bacteria
- Phenothiazines and Benzothiazines Synthesis and Activities
- Antimicrobial Resistance in Staphylococcus
- Quinazolinone synthesis and applications
- Infectious Diseases and Tuberculosis
- Antibiotics Pharmacokinetics and Efficacy
Which keywords describe Miguel Viveiros's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Antibiotic Resistance, Mycobacterium tuberculosis, Tuberculosis, Mycobacterium avium and Nontuberculous Mycobacteria.
- Antibiotic Pharmacokinetics
- Spinal Epidural Abscess
- Indirubin
- MRSA
- Phenothiazines
- Multidrug-Resistant Bacteria
- Synthesis
- Nontuberculous Mycobacteria
- Tuberculosis
- Antibiotic Resistance
- Diagnosis
- Epidemiology
- Treatment
- Mycobacterium tuberculosis
- Mycobacterium avium
- Antimicrobial
- ESKAPE Pathogens
- Biological Activities
- Antimicrobial Resistance
- Staphylococcus aureus
- Quinazoline
- Tuberculous Meningitis
- Critically Ill Patients
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Epidemiology2883 topics
- Diagnosis2612 topics
- Treatment2612 topics
- Antibiotic Resistance1862 topics
- Mycobacterium tuberculosis1481 topic
- Tuberculosis1481 topic
- Mycobacterium avium1131 topic
- Nontuberculous Mycobacteria1131 topic
- Antimicrobial802 topics
- Synthesis802 topics
- ESKAPE Pathogens731 topic
- Multidrug-Resistant Bacteria731 topic
- Biological Activities581 topic
- Phenothiazines581 topic
- Antimicrobial Resistance472 topics
- MRSA271 topic
- Staphylococcus aureus271 topic
- Indirubin221 topic
- Quinazoline221 topic
- Spinal Epidural Abscess211 topic
- Tuberculous Meningitis211 topic
- Antibiotic Pharmacokinetics201 topic
- Critically Ill Patients201 topic
Where does Miguel Viveiros work?
Miguel Viveiros's main affiliation in the publication record is Universidade Nova de Lisboa, Portugal.
How many publications and citations does Miguel Viveiros have?
OpenAlex counts 329 works and 13,486 citations for Miguel Viveiros, an h-index of 64, ranking #442,219 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Miguel Viveiros. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.